首頁 > 市場調查報告書 > 製藥

自體免疫疾病

市場調查報告書

商品編碼

1565605

白斑症治療的全球市場:類型·治療方法·終端用戶·不同地區的預測 (～2030年)

Global Vitiligo Treatment Market Research Report Information by Type, By Treatment, By End-User, and Region -Forecast till 2030

出版日期: 2024年08月10日 | 出版商:

Market Research Future | 英文 123 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預測期內，全球白斑症治療市場規模預計將以 6.20% 的複合年增長率成長。由於白斑症盛行率不斷上升、美學吸引力的重要性和意識不斷增強以及治療方案的進步，該市場正在不斷增長。

近年來，由於人均收入的增加、數位平台的引入以及對各種美容護理意識的增強，消費者的美學意識顯著提高。 ISAPS（國際美容整形外科學會）報告稱，2015年至2019年，全球非手術手術總數增加了27.3%。此外，美國整形外科醫生協會 (ASPS) 報告稱，從 2000 年到 2017 年，微創整容手術的數量增加了約 200%。此外，2018年進行了約1,590萬例微創美容手術，比2017年增加了2%。

區域展望

2023年，北美白斑症治療市場佔最大市場。這是人們對皮膚病認識的提高和醫療基礎設施更先進的結果。該地區對研發的重視促使引進了先進光療、生物製劑和外用藥物等創新療法。

由於白斑症治療的整合趨勢和有利的醫療保健政策，歐洲市場佔有率預計將位居第二。預計法國將成為歐洲地區成長最快的市場，德國預計將佔最大佔有率。

預計從 2024 年到 2032 年，亞太地區的白斑症治療市場將出現最快的成長。這是由於醫療保健成本增加和醫療保健基礎設施改善而促使獲得先進治療的機會增加的結果。此外，尋常性白斑症盛行率的不斷上升以及對美容和皮膚科治療的需求不斷增長也推動了市場的發展。

本報告提供全球白斑症治療的市場調查，彙整市場定義和概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·各地區的明細，競爭環境，主要企業簡介等資訊。

Global Vitiligo Treatment Market Research Report Information by Type (Segmental Vitiligo, Non-Segmental Vitiligo), By Treatment (Therapy, Surgery, Medication), By End-User (Hospitals, Ambulatory Clinics, Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)-Forecast till 2030

Market Overview

The Vitiligo Treatment Market industry is anticipated to experience a compound annual growth rate (CAGR) of 6.20% during the forecast period. The market is experiencing growth due to the increasing prevalence of vitligo, the increasing significance of aesthetic appeal and awareness, and the advancements in treatment options.

As a result of the increasing per capita income, the adoption of digital platforms, and the increasing awareness of various aesthetic treatments, there has been a substantial increase in beauty consciousness among consumers in recent years. Between 2015 and 2019, the International Society of Aesthetic Plastic Surgery (ISAPS) reported a 27.3% increase in the global total of non-surgical procedures. Furthermore, the American Society of Plastic Surgeons (ASPS) reported that the number of minimally invasive aesthetic procedures increased by approximately 200% from 2000 to 2017. Additionally, in 2018, approximately 15.9 million minimally invasive cosmetic procedures were conducted, representing a 2% increase from 2017.

Market Segment Insights

Segmental Vitiligo and Non-Segmental Vitiligo comprise the Vitiligo Treatment Market segmentation by Type.

A treatment that encompasses therapy, surgery, and medication is the basis for market segmentation.

The end-user segmentation of the market is based on Hospitals, Ambulatory Clinics, and Others.

Regional Perspectives

The market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World by region. In 2023, the North American Vitiligo Treatment Market held the greatest market share. As a result of the growing awareness of skin disorders and the development of a more sophisticated healthcare infrastructure. Innovative treatments, such as advanced phototherapy, biologics, and topical medications, have been introduced as a result of the region's strong emphasis on research and development.

The market share of the European Vitiligo Treatment Market is anticipated to be the second largest, as a result of the trend toward the integration of Vitiligo Treatment and the favorable health policies. Additionally, the France Vitiligo Treatment Market is anticipated to be the fastest-growing market in the European region, while the German Vitiligo Treatment Market was attributed to holding the largest market share.

From 2024 to 2032, the Asia-Pacific Vitiligo Treatment market is anticipated to experience the most rapid growth. This is the result of improved access to advanced therapies, which is facilitated by rising healthcare expenditures and the improvement of healthcare infrastructure. Additionally, the increasing prevalence of vitiligo and the increasing demand for cosmetic and dermatological remedies are substantial market drivers.

The Middle East, Africa, and Latin America comprise the Rest of the World. The primary factors that are influencing the expansion of Vitiligo Treatment in the Middle East and Africa. The Middle East and Africa region has encountered Increased global awareness and destigmatization of vitiligo are resulting in a higher demand for effective treatments and an increase in the number of diagnoses.

Major Players

Incyte (US), Bausch Health Companies Inc (Canada), Koninklijke Philips N.V. (Netherlands), Reddy's Laboratories Ltd (India), Strata Skin Sciences (US), Clinuvel Pharmaceuticals Ltd (Australia), ISSAR Pharmaceuticals Pvt. Ltd (India), Kernel Medical Equipment CO., LTD (China), LightSources (US), and Roivant Sciences Ltd. (Switzerland) are among the key companies in the Vitiligo Treatment Market.

1 EXECUTIVE SUMMARY

1.1 OVERVIEW
- 1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
- 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 GROWING IMPORTANCE OF THE AESTHETIC APPEAL AND AWARENESS
- 4.2.2 INCREASING PREVALENCE OF VITLIGO
4.3 RESTRAINTS
- 4.3.1 LACK OF TRAINED PROFESSIONALS
4.4 OPPORTUNITIES
- 4.4.1 RISING NUMBER OF CLINICAL TRIALS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION & SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE VITILIGO TREATMENT MARKET
- 5.3.1 IMPACT ON SUPPLY CHAIN
- 5.3.2 IMPACT ON REGION
- 5.3.3 IMPACT ON DEMAND AND SUPPLY

6 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE

6.1 OVERVIEW
6.2 SEGMENTAL VITILIGO
6.3 NON-SEGMENTAL VITILIGO

7 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE

7.1 OVERVIEW
7.2 THERAPY
- 7.2.1 DEPIGMENTATION
- 7.2.2 LIGHT
7.3 SURGERY
- 7.3.1 SKIN GRAFTING
- 7.3.2 BLISTER GRAFTING
- 7.3.3 MICRO-PIGMENTATION
7.4 MEDICATION
- 7.4.1 TOPICAL CORTICOSTEROIDS
- 7.4.2 IMMUNOSUPPRESSIVE

8 GLOBAL VITILIGO TREATMENT MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS
8.3 AMBULATORY CLINICS
8.4 OTHERS

9 GLOBAL VITILIGO TREATMENT MARKET, BY REGION

9.1 OVERVIEW
9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 FRANCE
- 9.3.3 UK
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 JAPAN
- 9.4.3 INDIA
- 9.4.4 SOUTH KOREA
- 9.4.5 AUSTRALIA
- 9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
- 9.5.1 MIDDLE EAST
- 9.5.2 AFRICA
- 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN VITILIGO TREATMENT MARKET
10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN VITILIGO TREATMENT MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1 PRODUCT APPROVALS/PRODUCT LAUNCHES/DRUG PIPELINE
- 10.6.2 MERGERS & ACQUISITIONS
10.7 MAJOR PLAYERS SALES ANALYSIS
- 10.7.1 SALES & OPERATING INCOME,
- 10.7.2 MAJOR PLAYERS R&D ANALYSIS,

11 COMPANY PROFILE

11.1 INCYTE
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 BAUSCH HEALTH COMPANIES INC.
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGIES
11.3 KONINKLIJKE PHILIPS N.V.
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 SWOT ANALYSIS
- 11.3.6 KEY STRATEGIES
11.4 DR. REDDY'S LABORATORIES LTD.
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 SWOT ANALYSIS
- 11.4.6 KEY STRATEGIES
11.5 STRATA SKIN SCIENCES
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 KEY STRATEGIES
11.6 CLINUVEL PHARMACEUTICALS LTD
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 SWOT ANALYSIS
- 11.6.6 KEY STRATEGIES
11.7 ISSAR PHARMACEUTICALS PVT. LTD.
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL ANALYSIS
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 KEY STRATEGIES
11.8 KERNEL MEDICAL EQUIPMENT CO., LTD.
- 11.8.1 COMPANY OVERVIEWS
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 KEY STRATEGIES
11.9 LIGHTSOURCES
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL ANALYSIS
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 KEY STRATEGIES
11.10 ROIVANT SCIENCES LTD.
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL ANALYSIS
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 PRODUCTS OFFERED
- 11.10.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES
12.2 RELATED REPORTS

簡介目錄圖表

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 3 GLOBAL VITILIGO TREATMENT MARKET, FOR SEGMENTAL VITILIGO, BY REGION, 2019-2030 (USD BILLION)
TABLE 4 GLOBAL VITILIGO TREATMENT MARKET, FOR NON-SEGMENTAL VITILIGO, BY REGION, 2019-2030 (USD BILLION)
TABLE 5 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 6 GLOBAL VITILIGO TREATMENT MARKET, FOR THERAPY, BY REGION, 2019-2030 (USD BILLION)
TABLE 7 GLOBAL VITILIGO TREATMENT MARKET, FOR DEPIGMENTATION, BY REGION, 2019-2030 (USD BILLION)
TABLE 8 GLOBAL VITILIGO TREATMENT MARKET, FOR LIGHT, BY REGION, 2019-2030 (USD BILLION)
TABLE 9 GLOBAL VITILIGO TREATMENT MARKET, FOR SURGERY, BY REGION, 2019-2030 (USD BILLION)
TABLE 10 GLOBAL VITILIGO TREATMENT MARKET, FOR SKIN GRAFTING, BY REGION, 2019-2030 (USD BILLION)
TABLE 11 GLOBAL VITILIGO TREATMENT MARKET, FOR BLISTER GRAFTING, BY REGION, 2019-2030 (USD BILLION)
TABLE 12 GLOBAL VITILIGO TREATMENT MARKET, FOR MICRO-PIGMENTATION, BY REGION, 2019-2030 (USD BILLION)
TABLE 13 GLOBAL VITILIGO TREATMENT MARKET, FOR MEDICATION, BY REGION, 2019-2030 (USD BILLION)
TABLE 14 GLOBAL VITILIGO TREATMENT MARKET, FOR TOPICAL CORTICOSTEROIDS, BY REGION, 2019-2030 (USD BILLION)
TABLE 15 GLOBAL VITILIGO TREATMENT MARKET, FOR IMMUNOSUPPRESSIVE, BY REGION, 2019-2030 (USD BILLION)
TABLE 16 GLOBAL VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 17 GLOBAL VITILIGO TREATMENT MARKET, FOR HOSPITALS, BY REGION, 2019-2030 (USD BILLION)
TABLE 18 GLOBAL VITILIGO TREATMENT MARKET, FOR AMBULATORY CLINICS, BY REGION, 2019-2030 (USD BILLION)
TABLE 19 GLOBAL VITILIGO TREATMENT MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)
TABLE 20 GLOBAL: VITILIGO TREATMENT MARKET, BY REGION, 2019-2030 (USD BILLION)
TABLE 21 NORTH AMERICA: VITILIGO TREATMENT MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 22 NORTH AMERICA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 23 NORTH AMERICA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 24 NORTH AMERICA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 25 NORTH AMERICA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 26 NORTH AMERICA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 27 NORTH AMERICA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 28 US: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 29 US: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 30 US: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 31 US: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 32 US: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 33 US: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 34 CANADA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 35 CANADA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 36 CANADA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 37 CANADA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 38 CANADA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 39 CANADA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 40 EUROPE: VITILIGO TREATMENT MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 41 EUROPE: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 42 EUROPE: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 43 EUROPE: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 44 EUROPE: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 45 EUROPE: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 46 EUROPE: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 47 GERMANY: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 48 GERMANY: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 49 GERMANY: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 50 GERMANY: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 51 GERMANY: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 52 GERMANY: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 53 FRANCE: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 54 FRANCE: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 55 FRANCE: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 56 FRANCE: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 57 FRANCE: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 58 FRANCE: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 59 UK: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 60 UK: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 61 UK: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 62 UK: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 63 UK: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 64 UK: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 65 ITALY: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 66 ITALY: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 67 ITALY: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 68 ITALY: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 69 ITALY: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 70 ITALY: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 71 SPAIN: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 72 SPAIN: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 73 SPAIN: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 74 SPAIN: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 75 SPAIN: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 76 SPAIN: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 77 REST OF EUROPE: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 78 REST OF EUROPE: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 79 REST OF EUROPE: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 80 REST OF EUROPE: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 81 REST OF EUROPE: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 82 REST OF EUROPE: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 83 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 84 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 85 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 86 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 87 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 88 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 89 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 90 CHINA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 91 CHINA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 92 CHINA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 93 CHINA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 94 CHINA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 95 CHINA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 96 JAPAN: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 97 JAPAN: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 98 JAPAN: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 99 JAPAN: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 100 JAPAN: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 101 JAPAN: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 102 INDIA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 103 INDIA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 104 INDIA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 105 INDIA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 106 INDIA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 107 INDIA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 108 SOUTH KOREA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 109 SOUTH KOREA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 110 SOUTH KOREA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 111 SOUTH KOREA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 112 SOUTH KOREA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 113 SOUTH KOREA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 114 AUSTRALIA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 115 AUSTRALIA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 116 AUSTRALIA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 117 AUSTRALIA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 118 AUSTRALIA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 119 AUSTRALIA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 120 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 121 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 122 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 123 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 124 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 125 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 126 REST OF THE WORLD: VITILIGO TREATMENT MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 127 REST OF THE WORLD: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 128 REST OF THE WORLD: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 129 REST OF THE WORLD: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 130 REST OF THE WORLD: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 131 REST OF THE WORLD: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 132 REST OF THE WORLD: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 133 MIDDLE EAST: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 134 MIDDLE EAST: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 135 MIDDLE EAST: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 136 MIDDLE EAST: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 137 MIDDLE EAST: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 138 MIDDLE EAST: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 139 AFRICA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 140 AFRICA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 141 AFRICA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 142 AFRICA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 143 AFRICA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 144 AFRICA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 145 LATIN AMERICA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 146 LATIN AMERICA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 147 LATIN AMERICA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 148 LATIN AMERICA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 149 LATIN AMERICA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 150 LATIN AMERICA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 151 MAJOR MANUFACTURERS IN VITILIGO TREATMENT MARKET
TABLE 152 MOST ACTIVE PLAYER IN VITILIGO TREATMENT MARKET
TABLE 153 PRODUCT APPROVALS/PRODUCT LAUNCHES/DRUG PIPELINE
TABLE 154 MERGERS & ACQUISITIONS
TABLE 155 INCYTE: PRODUCTS OFFERED
TABLE 156 INCYTE: KEY DEVELOPMENTS
TABLE 157 BAUSCH HEALTH COMPANIES INC.: PRODUCTS OFFERED
TABLE 158 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 159 DR. REDDY'S LABORATORIES LTD.: PRODUCTS OFFERED
TABLE 160 STRATA SKIN SCIENCES: PRODUCTS OFFERED
TABLE 161 STRATA SKIN SCIENCES: KEY DEVELOPMENTS
TABLE 162 CLINUVEL PHARMACEUTICALS LTD: PRODUCTS OFFERED
TABLE 163 ISSAR PHARMACEUTICALS PVT. LTD.: PRODUCTS OFFERED
TABLE 164 KERNEL MEDICAL EQUIPMENT CO., LTD.: PRODUCTS OFFERED
TABLE 165 LIGHTSOURCES: PRODUCTS OFFERED
TABLE 166 ROIVANT SCIENCES LTD.: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL VITILIGO TREATMENT MARKET STRUCTURE
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 3 MARKET DYNAMICS: GLOBAL VITILIGO TREATMENT MARKET
FIGURE 4 DRIVERS: IMPACT ANALYSIS
FIGURE 5 RESTRAINT: IMPACT ANALYSIS
FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL VITILIGO TREATMENT MARKET
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL VITILIGO TREATMENT MARKET
FIGURE 8 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE, 2022 AND 2030 (USD BILLION)
FIGURE 9 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2022 AND 2030 (USD BILLION)
FIGURE 10 GLOBAL VITILIGO TREATMENT MARKET, BY END USER, 2022 AND 2030 (USD BILLION)
FIGURE 11 GLOBAL: VITILIGO TREATMENT MARKET, BY REGION 2022 AND 2030 (USD BILLION)
FIGURE 12 GLOBAL: VITILIGO TREATMENT MARKET SHARE (%), BY REGION,
FIGURE 13 NORTH AMERICA: VITILIGO TREATMENT MARKET SHARE (%), BY COUNTRY
FIGURE 14 EUROPE: VITILIGO TREATMENT MARKET SHARE (%), BY COUNTRY
FIGURE 15 ASIA-PACIFIC: VITILIGO TREATMENT MARKET SHARE (%), BY COUNTRY,
FIGURE 16 REST OF THE WORLD: VITILIGO TREATMENT MARKET SHARE (%), BY COUNTRY,
FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 18 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN VITILIGO TREATMENT MARKET
FIGURE 19 GLOBAL VITILIGO TREATMENT MARKET: COMPETITIVE LANDSCAPE
FIGURE 20 MAJOR PLAYERS SALES & OPERATING INCOME,
FIGURE 21 MAJOR PLAYERS R&D EXPENDITURE,
FIGURE 22 INCYTE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 INCYTE: SWOT ANALYSIS
FIGURE 24 BAUSCH HEALTH COMPANIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BAUSCH HEALTH COMPANIES INC.: SWOT ANALYSIS
FIGURE 26 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS
FIGURE 28 DR. REDDY'S LABORATORIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 DR. REDDY'S LABORATORIES LTD.: SWOT ANALYSIS
FIGURE 30 STRATA SKIN SCIENCES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 CLINUVEL PHARMACEUTICALS LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 CLINUVEL PHARMACEUTICALS LTD: SWOT ANALYSIS
FIGURE 33 ROIVANT SCIENCES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ROIVANT SCIENCES LTD.: PRODUCTS OFFERED

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

白斑症市場:KOL的洞察

FAQ

白斑症治療的全球市場:類型·治療方法·終端用戶·不同地區的預測 (～2030年)

Global Vitiligo Treatment Market Research Report Information by Type, By Treatment, By End-User, and Region -Forecast till 2030

目錄

第1章摘要整理

第2章市場概要

第3章調查手法

第4章市場動態

第5章市場要素分析

第6章全球白斑症治療市場:各類型

第7章全球白斑症治療市場:各治療類型

第8章全球白斑症治療市場:各終端用戶

第9章全球白斑症治療市場:各地區

第10章競爭情形

第11章企業簡介

第12章附錄

Market Overview

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE

7 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE

8 GLOBAL VITILIGO TREATMENT MARKET, BY END USER

9 GLOBAL VITILIGO TREATMENT MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILE

12 APPENDIX

LIST OF TABLES

LIST OF FIGURES

白斑症治療的全球市場:類型·治療方法·終端用戶·不同地區的預測 (～2030年)

Global Vitiligo Treatment Market Research Report Information by Type, By Treatment, By End-User, and Region -Forecast till 2030

目錄

第1章 摘要整理

第2章 市場概要

第3章 調查手法

第4章 市場動態

第5章 市場要素分析

第6章 全球白斑症治療市場:各類型

第7章 全球白斑症治療市場:各治療類型

第8章 全球白斑症治療市場:各終端用戶

第9章 全球白斑症治療市場:各地區

第10章 競爭情形

第11章 企業簡介

第12章 附錄

Market Overview

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE

7 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE

8 GLOBAL VITILIGO TREATMENT MARKET, BY END USER

9 GLOBAL VITILIGO TREATMENT MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILE

12 APPENDIX

LIST OF TABLES

LIST OF FIGURES

第1章摘要整理

第2章市場概要

第3章調查手法

第4章市場動態

第5章市場要素分析

第6章全球白斑症治療市場:各類型

第7章全球白斑症治療市場:各治療類型

第8章全球白斑症治療市場:各終端用戶

第9章全球白斑症治療市場:各地區

第10章競爭情形

第11章企業簡介

第12章附錄